Novartis: Acute Coronary Syndrome trials
The registry lists 11 Acute Coronary Syndrome studies with Novartis as lead sponsor. 1 are open to participants now and 7 have results posted.
Phase 1 1Phase 2 2Phase 3 8Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi ArabiaNot yet recruitingNCT07684469Phase 4
- Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary SyndromeCompletedNCT04873934Phase 3Results posted
- MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers TrialCompletedNCT02678923Phase 1/2Results posted
- A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)CompletedNCT01156571Phase 3Results posted
- European Ambulance Acute Coronary Syndrome (ACS) Angiography TrialCompletedNCT01087723Phase 3Results posted
- Maintenance of Platelet Inhibition With CangrelorCompletedNCT00767507Phase 2Results posted
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.TerminatedNCT00385138Phase 3Results posted
- A Clinical Trial to Demonstrate the Efficacy of CangrelorTerminatedNCT00305162Phase 3Results posted
- Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARLWithdrawnNCT07625306Phase 3
- Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesActive, not recruitingNCT07102628Phase 3
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)CompletedNCT00093158Phase 3